MétaCan
Menu
← Back to cohort

Safety and Tolerability of a Combination of Curcumin, Omega-3 and Vitamin D: Results from the PASCOD Study, an RA Prevention Protocol

2025· article· en· W6909994730 on OpenAlexaffvenue

Bibliographic record

VenueThe Journal of Rheumatology · 2025
Typearticle
Languageen
FieldMedicine
TopicRheumatoid Arthritis Research and Therapies
Canadian institutionsUniversity of WinnipegHealth Sciences CentreManitoba HealthUniversity of Manitoba
Fundersnot available
KeywordsTolerabilityClinical trialArthritisProspective cohort studyRheumatoid arthritisIncidence (geometry)VitaminVitamin D and neurology

Abstract

fetched live from OpenAlex

Objectives Rheumatoid arthritis (RA) is an inflammatory autoimmune arthritis for which there is currently no cure. Recent research has focused on prevention strategies in individuals at increased risk of RA with the aim of reducing this risk. One such strategy involves dietary interventions. In a secondary analysis of a large prospective clinical trial (VITAL), vitamin D and omega-3 fatty acid supplementation have shown promise in reducing incident RA.[1] In a collagen induced arthritis murine model of RA, we showed that a diet supplemented with Curcumin, omega-3 and vitamin D (COD) reduced arthritis severity and incidence when given during the induction phase.[2] Based on these considerations, we are planning a prospective RA prevention trial using COD in anticitrullinated protein antibody (ACPA) positive individuals. However, there are no clinical trials which have evaluated the combined use of COD in humans. Thus, we conducted PASCOD (Pilot Assessment and Safety of COD) to evaluate the safety and tolerability of COD in healthy human volunteers. Methods Healthy volunteers aged 18-49 years with no history of RA or other autoimmune diseases were recruited (n=50) for a 4-week open-label pre-post design. Baseline visits included overall health and medications survey, anthropometric measures, functional status (RAPID3), a joint symptom questionnaire and a clinical assessment of 44 joints, all of which were repeated at the final visit. Blood specimens were collected for routine hematology and biochemistry. The study was powered to detect the rate of common side effects (>5% frequency), which was the primary outcome. Results Most reported side effects were mild (81.8%), with the most common, being heartburn (32%), fishy taste (30%), and abdominal bloating (24%), which mostly improved over time. Mean adherence was 97% for all 3 supplements. Reflective of this, we observed increases in eicosapentaenoic acid (EPA, p<0.0001), docosahexaenoic acid (DHA, p<0.0001) levels measured in plasma by gas chromatography, and vitamin D levels (p=0.01). Despite the absence of inflammatory arthritis, RAPID3 scores significantly decreased over the trial (p=0.048), driven by a reduction in self-reported joint pain visual analog scale (VAS, p=0.002). Self-reported joint pain score (p=0.008), fatigue VAS (p=0.008) and minutes of AM stiffness (p=0.01) all reduced after COD treatment (Figure). Conclusion Overall, 4 weeks of COD was well-tolerated, with high adherence and mild side effects which mostly improved over time. We observed improvements in self-reported symptoms relevant to individuals at risk for future RA development. This data suggests that COD supplementation is a feasible strategy for consideration in an RA prevention trial. [1.] Hahn J. BMJ 2022:376:e066452. [2.] Hemshekhar M. Arthritis Res Ther 2021;23(1):39.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.007
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Non-randomized trial · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.008
Threshold uncertainty score0.037

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0070.004
Meta-epidemiology (narrow)0.0030.001
Meta-epidemiology (broad)0.0040.002
Bibliometrics0.0010.001
Science and technology studies0.0010.002
Scholarly communication0.0010.001
Open science0.0020.001
Research integrity0.0020.003
Insufficient payload (model declined to judge)0.0080.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.016
GPT teacher head0.326
Teacher spread0.310 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNon-randomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueThe Journal of Rheumatology→Same topicRheumatoid Arthritis Research and Therapies→French-language works237,207→